Viral hepatitis B and C screening by collaboration of local administrative organization, 2022-2023
DOI:
https://doi.org/10.14456/dcj.2024.47Keywords:
Viral Hepatitis B and C, Screening, Local Administrative OrganizationAbstract
In Thailand, it was estimated that there were approximately 2.2 million chronic hepatitis B cases and around 300,000 to 400,000 chronic hepatitis C cases in 2014. There are a significant number of infected individuals who have no access to services because they are unaware of their infection. Division of AIDS and STIs (DAS), Department of Disease Control, implemented a hepatitis B and C screening project to enhance participation of local administrative organizations (LAOs) in support of targeted population to access to services. This article aims to present the project performance results during October 1, 2021-September 30, 2023. The DAS supported HBsAg and Anti-HCV rapid test kits for targeted populations born before 1992 or having risk of hepatitis B and C infection in 76 provinces. Local staff collected data by using a report form and recorded in a computer program. Data analysis used descriptive statistics. The results found that there were 43,402 and 138,594 persons screened for hepatitis B, 46,572 and 146,823 persons screened for hepatitis C in fiscal year 2022-2023, respectively; the mean ages were 49 years and 52 years, respectively. Of these, 2.42% and 2.43% of participants tested positive for HBsAg, and 0.76% and 1.34% of participants tested positive for HCV antibody, respectively. Among anti-HCV positive participants, 14.97% and 36.15% were tested HCV Viral load and 69.81% and 52.32% of them were detected, respectively. For collaboration with LAOs, most of LAOs supported their personnels and places for screening service, including service public relations. Some LAOs supported their budget for screening. We recommend promoting awareness of people and local networks to danger of hepatitis B and C diseases to increase service accessibility, mobilizing resources and sustainable collaboration, including developing referral system for infected persons to treatment.
Downloads
References
World Health Organization. Guidance for country validation of viral hepatitis elimination and path to elimination [Internet]. 2023 [cited 2024 Jul 4]. Available from: https://iris.who.int/bitstream/handle/10665/373186/9789240078635-eng.pdf?sequence=1
World Health Organization. New report highlights global progress on reducing HIV, viral hepatitis and sexually transmitted infections and signals need for renewed efforts to reach 2030 targets [Internet]. 2021 [cited 2024 Jul 4]. Available from: https://www.who.int/news/item/20-05-2021-new-report-highlights-global-progress-on-reducing-hiv-viral-hepatitis-and-sexually-transmitted-infections-and-signals-need-for-renewed-efforts-to-reach-2030-targets
World Health Organization. WHO releases first-ever global guidance for country validation of viral hepatitis B and C elimination [Internet]. 2021 [cited 2024 Jul 4]. Available from: https://www.who.int/news/item/25-06-2021-who-releases-first-ever-global-guidance-for-country-validation-of-viral-hepatitis-b-and-c-elimination
Wasitthankasem R, Posuwan N, Vichaiwattana P, Theamboonlers A, Klinfueng S, Vuthitanachot V, et al. Decreasing hepatitis C virus Infection in Thailand in the past decade: evidence from the 2014 national survey. PLoS ONE 2016;11(2):e0149362.
Posuwan N, Wanlapakorn N, Sa-Nguanmoo P, Wasitthankasem R, Vichaiwattana P, Klinfueng S, et al. The success of a universal hepatitis B immunization program as part of Thailand’s EPI after 22 Years’ implementation. PLOS One 2016;11(3):e0150499.
International Agency for Research on Cancer, World Health Organization. Thailand cancer statistics 2022 [Internet]. [cited 2024 Jul 4]. Available from: https://gco.iarc.who.int/media/globocan/factsheets/populations/764 -thailand-fact-sheet.pdf
Thunyavinichkul P, Kitisupornpun S, Pormme N, Wasusophaphol W, Sangsawang S, Arunthong S, et al. Prevalence of chronic hepatitis B and hepatitis C virus infection in Nongpakrang Subdistrict, Chiang Mai Province. Journal of the Department of Medical Services 2017;42(2):102-9. (in Thai)
Srisingh K, Ngoenmak T, Padsee N, Poovorawan Y. Prevalence of chronic hepatitis B in Phitsanulok Province, Thailand. Thai Journal of Pediatrics 2015;54(3):200-6. (in Thai)
Leroi C, Adam P, Khamduang W, Kawilapat S, Ngo-Giang-Huong N, Ongwandee S, et al. Prevalence of chronic hepatitis B virus infection in Thailand: a systematic review and meta-analysis. Int J Infect Dis 2016;51:36-43.
Wasitthankasem R, Pimsingh N, Treesun K, Posuwan N, Vichaiwattana P, Auphimai C, et al. Prevalence of Hepatitis C virus in an endemic area of Thailand: burden assessment toward HCV elimination. Am J Trop Med Hyg 2020;103(1):175-82.
Vandelaer S, Hirankarn N. Prevalence of HCV infection at King Chulalongkorn Memorial Hospital. Chulalongkorn Medical Journal 2018;62(1):67-78. (in Thai)
Intharasongkroh D, Limothai U, Atimong W, Sawangsub T. The biology of hepatitis B virus: a review. J Hematol Transfus Med 2021;31(2):169-86. (in Thai)
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Disease Control Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the Disease Control Journal are considered as academic work, research or analysis of the personal opinion of the authors, not the opinion of the Thailand Department of Disease Control or editorial team. The authors must be responsible for their articles.